-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Cuts Position in AngioDynamics, Inc. (NASDAQ:ANGO)
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Cuts Position in AngioDynamics, Inc. (NASDAQ:ANGO)
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. trimmed its position in AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) by 2.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,528 shares of the medical instruments supplier's stock after selling 1,935 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. owned 0.20% of AngioDynamics worth $1,627,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Texas Permanent School Fund raised its holdings in shares of AngioDynamics by 2.1% during the 2nd quarter. Texas Permanent School Fund now owns 28,029 shares of the medical instruments supplier's stock valued at $542,000 after buying an additional 580 shares during the period. US Bancorp DE raised its holdings in shares of AngioDynamics by 36.2% during the 2nd quarter. US Bancorp DE now owns 2,562 shares of the medical instruments supplier's stock valued at $50,000 after buying an additional 681 shares during the period. Legal & General Group Plc raised its holdings in shares of AngioDynamics by 0.9% during the 2nd quarter. Legal & General Group Plc now owns 93,102 shares of the medical instruments supplier's stock valued at $1,802,000 after buying an additional 851 shares during the period. Brinker Capital Investments LLC raised its holdings in shares of AngioDynamics by 2.3% during the 1st quarter. Brinker Capital Investments LLC now owns 41,539 shares of the medical instruments supplier's stock valued at $895,000 after buying an additional 929 shares during the period. Finally, Mutual of America Capital Management LLC raised its holdings in shares of AngioDynamics by 16.7% during the 2nd quarter. Mutual of America Capital Management LLC now owns 6,513 shares of the medical instruments supplier's stock valued at $126,000 after buying an additional 934 shares during the period. 94.94% of the stock is currently owned by hedge funds and other institutional investors.
Get AngioDynamics alerts:Wall Street Analyst Weigh In
Several equities research analysts recently commented on ANGO shares. Raymond James dropped their target price on AngioDynamics from $25.00 to $22.00 and set a "strong-buy" rating on the stock in a report on Friday, January 6th. StockNews.com began coverage on AngioDynamics in a report on Wednesday, October 12th. They set a "hold" rating on the stock.
AngioDynamics Price Performance
ANGO stock opened at $13.32 on Friday. The company has a quick ratio of 1.30, a current ratio of 2.16 and a debt-to-equity ratio of 0.12. AngioDynamics, Inc. has a 52-week low of $11.71 and a 52-week high of $24.87. The stock's 50 day moving average is $13.34 and its two-hundred day moving average is $17.49. The company has a market capitalization of $521.26 million, a PE ratio of -16.05 and a beta of 0.66.AngioDynamics Profile
(Get Rating)
AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.
Featured Articles
- Get a free copy of the StockNews.com research report on AngioDynamics (ANGO)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating).
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
三菱日联国赛资产管理有限公司(Mitsubishi UFJ Kokusai Asset Management Co.)在最近提交给美国证券交易委员会(SEC)的13F文件中称,该公司第三季度将其在AngioDynamic,Inc.(纳斯达克代码:Ango-Get Rating)的持仓削减了2.4%。该公司在本季度出售了1,935股后,持有这家医疗器械供应商的79,528股股票。截至最近一个季度末,三菱UFJ国赛资产管理有限公司持有AngioDynamics 0.20%的股份,价值1,627,000美元。
其他一些大型投资者最近也调整了对该公司的持股。德克萨斯永久学校基金在第二季度增持了2.1%的AngioDynamic股票。德克萨斯永久学校基金现在拥有28,029股这家医疗器械供应商的股票,价值542,000美元,在此期间又购买了580股。US Bancorp DE在第二季度将其持有的AngioDynamic股票增加了36.2%。在此期间,US Bancorp DE又购买了681股,现在拥有2562股这家医疗器械供应商的股票,价值5万美元。Legal&General Group Plc在第二季度将其持有的AngioDynamic股票增加了0.9%。Legal&General Group Plc现在拥有这家医疗器械供应商93,102股股票,价值1,802,000美元,在此期间又购买了851股。Brinker Capital Investments LLC在第一季度将其持有的AngioDynamic股票增加了2.3%。Brinker Capital Investments LLC现在拥有这家医疗器械供应商41,539股股票,价值895,000美元,在此期间又购买了929股。最后,美国互惠资本管理公司在第二季度将其持有的AngioDynamic股票增加了16.7%。美国互惠资本管理有限责任公司现在拥有这家医疗器械供应商6513股股票,价值12.6万美元,在此期间又购买了934股。94.94%的股票目前由对冲基金和其他机构投资者持有。
到达血管动力学警报:华尔街分析师也加入进来
几位股票研究分析师最近对Ango股票发表了评论。雷蒙德·詹姆斯将AngioDynamics的目标价从25.00美元下调至22.00美元,并在1月6日星期五的一份报告中对该股设定了“强势买入”评级。StockNews.com在10月12日星期三的一份报告中开始报道AngioDynamic。他们对该股设定了“持有”评级。
血管动力学性价比
安戈股票上周五开盘报13.32美元。该公司的速动比率为1.30,流动比率为2.16,债务权益比率为0.12。AngioDynamic,Inc.的52周低点为11.71美元,52周高位为24.87美元。该股的50日移动均线切入位为13.34美元,200日移动均线切入位为17.49美元。该公司市值为5.2126亿美元,市盈率为-16.05,贝塔系数为0.66。血管动力学概况
(获取评级)
AngioDynamic公司设计、制造和销售各种医疗、手术和诊断设备,由专业保健提供商用于治疗外周血管疾病和血管通路,并用于美国和国际上的肿瘤学和外科环境。
专题文章
- 免费获取StockNews.com关于血管动力学的研究报告(Ango)
- 市场回顾周-1/16-1/20
- Old Dominion是否表明Trucking正在踩刹车?
- 诺德斯特龙对零售业降价的担忧
- 埃克森美孚股票:在Buy Point附近
- 高股息率的必和必拓认为中国推动了23年的增长
想看看其他对冲基金持有安戈的哪些股份吗?访问HoldingsChannel.com获取AngioDynamic,Inc.(纳斯达克:Ango-Get Rating)的最新13F备案和内幕交易信息。
接受《血管动力学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对AngioDynamic和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧